Also known as: traveler's diarrhea, typhoid fever, enteric fever, Salmonella Typhi, ETEC
Overview
Travelers' diarrhea (TD) is acute diarrheal illness in travelers, most commonly bacterial (enterotoxigenic E. coli [ETEC] predominant; also Campylobacter, Shigella, Salmonella, EAEC), occasionally viral (norovirus) or parasitic. Typhoid fever (enteric fever) is systemic febrile illness caused by Salmonella enterica serotype Typhi (or Paratyphi A/B/C), invading via small bowel Peyer patches.
Epidemiology
TD affects 20-50% of travelers to high-risk regions (South/Southeast Asia, Africa, Latin America). Typhoid: ~11-21 million cases globally yearly, ~5,700 US cases (mostly returning travelers from South Asia). Rising drug resistance — extensively drug-resistant (XDR) typhoid emerged in Pakistan in 2016 and is spreading.
Try two board-style Travelers' Diarrhea and Typhoid Fever questions
Real questions from the FirstPassPA bank, with the full explanation. Pick an answer — no signup, no email.
Question 1Infectious DiseaseMedium
A 27-year-old man presents with 6 days of progressively worsening fever, frontal headache, and dull abdominal pain. He returned 10 days ago from a 3-week trip to rural India, where he ate from street vendors and was not vaccinated before travel. His temperature is 39.6°C (103.3°F) but his pulse is only 68/min. Abdominal exam reveals mild diffuse tenderness and a palpable spleen tip, and a few faint salmon-colored macules are noted on his trunk. He has not yet received any antibiotics. Which of the following is the most appropriate next diagnostic test?
ABone marrow aspiration
BStool culture sampling
CBlood culture sampling
DWidal antibody serology
Reveal answer & full explanation
Correct answer: C — Blood culture sampling
ABone marrow aspiration
BStool culture sampling
CBlood culture sampling✓
DWidal antibody serology
Why Blood culture sampling is correct
The vignette is classic enteric (typhoid) fever: a returning traveler from South Asia with stepwise rising fever, relative bradycardia (Faget sign, pulse 68/min despite 39.6°C), headache, abdominal pain, splenomegaly, and rose spots.
Blood cultures are the standard first-line confirmatory test for Salmonella Typhi and have their highest yield (sensitivity 40-80%) during the first week of illness, and this patient is on day 6.
They must be drawn before empiric antibiotics, which sharply reduce culture yield; the patient is antibiotic-naive, making this the ideal moment to obtain them.
Why the others are wrong
Widal antibody serology is an older antibody test for typhoid with poor sensitivity and specificity; it is not recommended where culture is available and should not replace blood cultures.
Stool culture sampling can grow Salmonella Typhi, but its yield is low early and rises only later in the illness, so it is inferior to blood culture as the first test during week 1.
Bone marrow aspiration for culture has the highest overall yield (about 90%) and stays positive even after antibiotics, but it is invasive and reserved for culture-negative or previously treated cases; blood culture is the appropriate first step in an untreated patient.
Question 2Infectious DiseaseMedium
A 24-year-old man is hospitalized after returning from a 4-week trip to South Asia with stepwise rising fevers to 39.8°C, headache, and abdominal pain. Exam shows a pulse of 76/min despite the fever, splenomegaly, and faint salmon-colored macules on the trunk. Blood cultures grow Salmonella enterica serotype Typhi, and he is started on ceftriaxone. He is now in the third week of illness. Which of the following complications is he most likely to develop?
AFulminant toxic megacolon
BAcute ascending cholangitis
CTerminal ileal perforation
DHemolytic uremic syndrome
Reveal answer & full explanation
Correct answer: C — Terminal ileal perforation
AFulminant toxic megacolon
BAcute ascending cholangitis
CTerminal ileal perforation✓
DHemolytic uremic syndrome
Why Terminal ileal perforation is correct
S. Typhi invades and multiplies within the lymphoid Peyer patches of the terminal ileum; the resulting ulceration peaks in the third week of illness, when intestinal perforation and hemorrhage are the classic and most feared complications.
This patient's presentation (stepwise fever, relative bradycardia/Faget sign, rose spots, splenomegaly, South Asia travel) plus the week-3 timing places him squarely at risk for perforation at an ulcerated Peyer patch, which presents with peritoneal signs and hypotension.
Why the others are wrong
Fulminant toxic megacolon is a complication of Clostridioides difficile colitis and inflammatory bowel disease, not of typhoid; S. Typhi causes focal ileal ulceration rather than diffuse colonic dilation.
Hemolytic uremic syndrome follows Shiga-toxin-producing E. coli (EHEC) infection, which is why antibiotics are avoided in suspected EHEC; it is not a feature of typhoid fever.
Acute ascending cholangitis results from biliary obstruction with infection; although S. Typhi can chronically colonize the gallbladder (carrier state), the acute week-3 lesion is ileal ulceration with perforation, not cholangitis.
🔒 Free preview limit reached
Keep reading — start your free trial
You've read your 2 free diagnosis previews. Create your free account to unlock the full Travelers' Diarrhea and Typhoid Fever outline — plus all 514 diagnoses, 6,500+ board-style questions, flashcards, and an AI tutor. Your 7-day free trial includes everything, and there's no credit card required.
Consumption of contaminated water, raw produce, undercooked meat/seafood, unpasteurized dairy
Staying in budget accommodations, street food
Younger age, achlorhydria, PPI use
Immunocompromise
Unvaccinated against typhoid (for typhoid)
Pathophysiology
TD: ETEC adheres to small bowel and secretes heat-labile (LT, cholera-like) and heat-stable (ST) toxins causing secretory diarrhea. Other bacterial pathogens cause inflammatory or invasive disease. Typhoid: S. Typhi invades M cells of Peyer patches, multiplies intracellularly within macrophages, disseminates via reticuloendothelial system, and reseeds the gallbladder and gut — explaining the biphasic clinical course and chronic carrier state.
Clinical presentation
Symptoms
Travelers' diarrhea (typical onset 4-14 days into travel): ≥3 loose stools/24 h with nausea, cramping, urgency, low-grade fever; usually self-limited in 3-5 days
Dysentery: bloody/mucoid stools, high fever, tenesmus — suggests Shigella, Campylobacter, EHEC, or amebiasis
Typhoid fever (incubation 6-30 days): stepwise rising fever to 39-40°C, relative bradycardia (Faget sign), prolonged headache, abdominal pain, constipation (early; diarrhea later in 'pea-soup' form), splenomegaly, rose spots (faint salmon-colored macules on trunk in ~30%), encephalopathy in severe disease
Intestinal complications (week 3): perforation and hemorrhage at Peyer patches
Chronic carrier state (~2-5%): persistent shedding from gallbladder; classic 'Typhoid Mary'
Signs / physical exam
TD: signs of dehydration; non-distended abdomen with diffuse tenderness
Typhoid: relative bradycardia for degree of fever, hepatosplenomegaly, rose spots (small, faint macules on trunk), altered mental status in severe cases
Perforation: peritoneal signs, hypotension
Classic findings
Returning traveler from South Asia with stepwise fever, relative bradycardia, rose spots, and abdominal pain — typhoid fever. Traveler with watery, non-bloody diarrhea on day 3 of a trip to a tropical destination — most likely ETEC travelers' diarrhea.
Differential diagnosis
Viral gastroenteritis — Short duration, vomiting prominent, no inflammatory markers; norovirus on cruise ships
Inflammatory bowel disease — Chronic disease, family history; endoscopy
Diagnostic workup
Diagnostic criteria
Travelers' diarrhea: clinical syndrome + travel history. Typhoid: positive culture (blood, bone marrow, or stool) for Salmonella Typhi.
Labs
Travelers' diarrhea: stool culture, multiplex PCR panel, O&P if persistent; not routinely needed for mild self-limited illness
Typhoid: blood cultures (highest yield first week of illness; sensitivity 40-80%), bone marrow culture (highest yield, ~90%, but invasive), stool culture (later in illness), urine culture
CBC: typhoid often shows normal or low WBC with relative bradycardia; eosinopenia
CMP, LFTs (mild transaminitis in typhoid)
Serology (Widal test) — poor specificity; not recommended where culture available
Malaria smears in febrile returned traveler — coinfection or alternative diagnosis
Imaging
Abdominal radiograph or CT if perforation suspected (free air, ileal pneumatosis)
Ultrasound for hepatosplenomegaly, abscess
Diagnostic algorithm
Syndrome
Likely Pathogen
Treatment
Notes
TD - mild watery
ETEC > other E. coli
ORS ± loperamide
Antibiotics usually unnecessary
TD - moderate
ETEC, Campylobacter, Shigella
Azithromycin 1 g x 1
Preferred in Asia (cipro resistance)
TD - severe/dysenteric
Shigella, Campylobacter, EIEC
Azithromycin 1 g x 1
No loperamide; consider stool studies
TD - chronic >14 d
Giardia, Cyclospora, parasites
Targeted therapy
Stool antigen/PCR
Typhoid - uncomplicated
Salmonella Typhi
Azithromycin 1 g then 500 mg x 5-7 d
Outpatient if stable
Typhoid - severe / hospitalized
Salmonella Typhi (± XDR)
Ceftriaxone 2 g IV x 7-14 d; meropenem for XDR
Add dexamethasone for shock/AMS
Chronic typhoid carrier
Salmonella Typhi (gallbladder)
Ciprofloxacin 4-6 wk ± cholecystectomy
Public health implications
Travelers' diarrhea and typhoid fever — empiric therapy by syndrome.
Treatment
First-line
Travelers' diarrhea — based on severity:
• Mild: oral rehydration, loperamide (avoid if dysenteric); antibiotics not required
• Moderate: azithromycin 1 g PO × 1 (or 500 mg daily × 1-3 days) — preferred globally given fluoroquinolone resistance, especially in Asia for Campylobacter
• Alternative: ciprofloxacin 500 mg PO BID × 1-3 days (avoid in Asia due to Campylobacter resistance); rifaximin 200 mg PO TID × 3 days (non-absorbed; good for non-invasive ETEC; not effective for invasive infection)
• Severe/dysenteric: azithromycin 1 g PO × 1 (preferred) — covers Shigella, Campylobacter; do NOT use loperamide
Typhoid fever:
• Azithromycin 1 g PO × 1 then 500 mg daily × 5-7 days for uncomplicated outpatient cases
• Ceftriaxone 2 g IV daily × 7-14 days for severe disease or hospitalized patients
• Carbapenems (meropenem) for XDR strains from Pakistan
• Dexamethasone for severe disease with shock/altered mental status (reduces mortality)
• Fluoroquinolones (ciprofloxacin) historically first-line but increasing resistance — reserve for known susceptible strains
Second-line / adjunct
Prevention — food and water precautions ('boil it, cook it, peel it, or forget it'); typhoid vaccine for travelers to endemic areas (inactivated Vi polysaccharide IM single dose or live attenuated oral Ty21a 4-dose regimen)
Chemoprophylaxis: rifaximin for high-risk short-term travelers with comorbidities (not routinely recommended due to resistance concerns)
Bismuth subsalicylate 524 mg QID — modestly effective TD prophylaxis; many side effects
Chronic typhoid carriers: prolonged ciprofloxacin (4-6 weeks) or cholecystectomy
HUS from EHEC (avoid antibiotics if EHEC suspected — increases HUS risk)
PANCE pearls
Azithromycin has displaced ciprofloxacin as first-line for moderate-severe travelers' diarrhea — Campylobacter fluoroquinolone resistance is high in South and Southeast Asia.
Loperamide is safe in non-bloody, non-febrile TD as adjunctive symptom relief; avoid in dysentery or invasive disease.
Stepwise rising fever, relative bradycardia, and rose spots in a returned traveler from South Asia — think typhoid; obtain blood cultures BEFORE antibiotics.
XDR typhoid (resistant to ampicillin, TMP-SMX, fluoroquinolones, third-gen cephalosporins) requires carbapenems — increasingly imported from Pakistan.
Typhoid vaccination is recommended for any traveler to South Asia, sub-Saharan Africa, or other typhoid-endemic regions; inactivated vaccine is single-dose IM.
References
CDC Yellow Book 2024 — Travelers' Diarrhea and Typhoid and Paratyphoid Fever chapters
ISTM 2017 — Riddle et al., Guidelines for the prevention and treatment of travelers' diarrhea: a graded expert panel report
IDSA 2017 — Shane et al., 2017 Infectious Diseases Society of America Clinical Practice Guidelines for the Diagnosis and Management of Infectious Diarrhea (Clin Infect Dis)
WHO Typhoid — WHO Guidelines for the management of typhoid fever (most recent edition)
Practice Infectious Disease questions on FirstPassPA
Turn this outline into retention. 6,500+ board-style questions with an AI tutor that explains every answer — free to start, no card required.
Educational use only. This outline is a study aid for PA students and is not medical advice or a substitute for clinical judgment. FirstPassPA is an independent study tool and is not affiliated with, endorsed by, or sponsored by NCCPA or PAEA. PANCE® and PANRE® are registered trademarks of the National Commission on Certification of Physician Assistants; End of Rotation™ is a program of the Physician Assistant Education Association.